# EDGAR Filing Document

**Accession Number:** 0001651311
**File Stem:** 0001193125-25-221809
**Filing Date:** 2025-9
**Character Count:** 2961
**Document Hash:** 75480e500d868962c1f84d96b68e61c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-221809.hdr.sgml**: 20250929

**ACCESSION NUMBER**: 0001193125-25-221809

**CONFORMED SUBMISSION TYPE**: SC14D9C

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250929

**DATE AS OF CHANGE**: 20250929

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Merus N.V.
- **CENTRAL INDEX KEY:** 0001651311
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC14D9C
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-89510
- **FILM NUMBER:** 251352378

**BUSINESS ADDRESS:**
- **STREET 1:** YALELAAN 62
- **CITY:** 3584 CM UTRECHT
- **STATE:** DE
- **BUSINESS PHONE:** 31 030 253 8800

**MAIL ADDRESS:**
- **STREET 1:** YALELAAN 62
- **CITY:** 3584 CM UTRECHT
- **STATE:** DE

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Merus B.V.
- **DATE OF NAME CHANGE:** 20150819
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Merus N.V.
- **CENTRAL INDEX KEY:** 0001651311
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC14D9C

**BUSINESS ADDRESS:**
- **STREET 1:** YALELAAN 62
- **CITY:** 3584 CM UTRECHT
- **STATE:** DE
- **BUSINESS PHONE:** 31 030 253 8800

**MAIL ADDRESS:**
- **STREET 1:** YALELAAN 62
- **CITY:** 3584 CM UTRECHT
- **STATE:** DE

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Merus B.V.
- **DATE OF NAME CHANGE:** 20150819

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE 14D-9**

**SOLICITATION/RECOMMENDATION STATEMENT** 

**UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934** 

## MERUS N.V.
**(Name of Subject Company)** 

**(Name of Person Filing Statement)** 

**Common Shares, nominal value €0.09 per share** 

**(Title of Class of Securities)** 

**N5749R100** 

**(CUSIP Number of Class of Securities)** 

**Sven (Bill) Ante Lundberg** 

**c/o Merus US, Inc.** 

**139 Main St. Suite 302** 

**Cambridge, MA 02142** 

**(617) 401-4499** 

**(Name, address and telephone number of person authorized to receive notices and communications on behalf of the persons filing statement)** 

***With a copy to:***

**Peter N. Handrinos** 

**R. Scott Shean** 

**Brian R. Umanoff** 

**Latham & Watkins LLP** 

**200 Clarendon Street** 

**Boston, MA 02116** 

**(617) 948-6000** 

☒ Check the box if the filing relates solely to preliminary communications made before the commencement of a
tender offer.

------

The information set forth under Items 1.01, 7.01 and 9.01 of the Current Report on Form 8-K filed by Merus N.V. on September 29, 2025 (including all exhibits attached thereto) is incorporated herein by reference.